reading telehealth threads from 2024 and half of it aged badly
Long-ish post, sorry. tl;dr at the bottom. I have been tracking state board against eGFR for 35 weeks because I could not find anyone who had. The correlation is weaker than I expected, which is itself mildly interesting given how confidently people link the two in here. Caveats up front: one person, one lab, one…
This is correct. The shortage list does expire and the rules change.
Are we talking 503A or 503B?
the shortage list is temporary, it ends and compounding becomes illegal again
This is correct.
Adding to this: state board is doing more work than the comment implies.
That is net peptide content, not purity. Different number, different meaning.
503B compounding is different from 503A, different rules, different legality
503B compounding is different from 503A, different rules, different legality
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.